Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 7.44
-0.22 (-2.87%)
Feb 10, 2026, 2:09 PM CET
Hyloris Pharmaceuticals Employees
Hyloris Pharmaceuticals had 50 employees as of June 30, 2025. The number of employees increased by 1 or 2.04% since the number was reported on December 31, 2024.
Employees
50
Change
1
Growth
2.04%
Revenue / Employee
€169,180
Profits / Employee
€128,240
Market Cap
214.48M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 50 | 1 | 2.04% |
| Dec 31, 2024 | 49 | 8 | 19.51% |
| Dec 31, 2023 | 41 | 4 | 10.81% |
| Dec 31, 2022 | 37 | 16 | 76.19% |
| Dec 31, 2021 | 21 | 13 | 159.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 8,600 |
| argenx SE | 1,599 |
| European Medical Solutions | 123 |
| Onward Medical | 103 |
| Celyad Oncology | 19 |
| Oxurion NV | 11 |
| BioSenic | 7 |